Results 21 to 30 of about 112,202 (290)

Effect of beta-blockers on exacerbation rate and lung function in chronic obstructive pulmonary disease (COPD)

Respiratory Research, 2017
Background Beta-blockers are commonly prescribed for patients with cardiovascular disease. Providers have been wary of treating chronic obstructive pulmonary disease (COPD) patients with beta-blockers due to concern for bronchospasm, but retrospective ...
Sean Duffy, Robert Marron, Helen Voelker, Richard Albert, John Connett, William Bailey, Richard Casaburi, J. Allen Cooper, Jeffrey L. Curtis, Mark Dransfield, MeiLan K. Han, Barry Make, Nathaniel Marchetti, Fernando Martinez, Stephen Lazarus, Dennis Niewoehner, Paul D. Scanlon, Frank Sciurba, Steven Scharf, Robert M. Reed, George Washko, Prescott Woodruff, Charlene McEvoy, Shawn Aaron, Don Sin, Gerard J. Criner, the NIH COPD Clinical Research Network and the Canadian Institutes of Health Research   +26 more
doaj   +1 more source

A Clinical-Epidemiological Study on Beta-Blocker Poisonings Based on the Type of Drug Overdose

Journal of Toxicology, 2023
Background. Beta‐blockers carry a high risk of potentially causing fatal poisoning if overdosed. We aimed to assess the clinical and epidemiological characteristics of patients with beta-blocker poisoning. Methods.
Nastaran Eizadi-Mood, Mahtab Adib, Arman Otroshi, Gholamali Dorooshi, Rokhsareh Meamar   +4 more
doaj   +1 more source

Drug Use Evaluation of Beta-Blockers in Medical Wards of Nedjo General Hospital, Western Ethiopia

Cardiovascular Therapeutics, 2020
Introduction. Beta-blocker use evaluation is a performance method that focuses on the evaluation of beta-blocker use processes to achieve optimal patient outcomes.
Ginenus Fekadu, Firomsa Bekele, Kumera Bekele, Sagni Hanbisa, Gemechis Belay, Mudasir Maqbool   +5 more
doaj   +1 more source

Beta adrenergic blockers poisoning [PDF]

ABC: časopis urgentne medicine, 2016
AIM: To demonstrate the basic characteristics in terms of clinical features and a basic method of treatment in β-adrenergic blockers poisoning. MATERIALS AND METHODS: Review of the available literature, the protocols of departments that participated in ...
Tadić Milorad, Stanimirović Marijana
doaj  

Antihypertensive Drug Use and the Risk of Depression: A Systematic Review and Network Meta-analysis

Frontiers in Pharmacology, 2021
Background: Although numerous cohort studies have reported an association between antihypertensives use and depression, the exact effect of antihypertensives on depression remains unclear.Objective: To clarify the association between antihypertensives ...
Ying Li, Yuanming Fan, Yangyang Sun, Raphael N. Alolga, Pingxi Xiao, Gaoxiang Ma   +5 more
doaj   +1 more source

Topical questions of beta-blockers application in clinical practice [PDF]

Системные гипертензии, 2014
The present review shows the modern view on the possibilities of beta-blockers application in different clinical situations. The class of beta-blockers is a heterogeneous group in terms of clinical usage.
D V Nebieridze
doaj  

The progress and controversial of the use of beta blockers in patients with heart failure with a preserved ejection fraction

International Journal of Cardiology: Heart & Vasculature, 2020
Beta blockers are a recommended therapy in patients with heart failure with reduced ejection fraction(HFrEF). Beta blockers markedly and unequivocally reduce mortality in patients with heart failure with reduced ejection fraction. However, the beneficial
Xizhen Xu, Dao Wen Wang
doaj  

The association between beta-blocker use and chronic obstructive pulmonary disease risk, severity, and exacerbation

Medical Journal of Babylon, 2021
Background: There is controversy about the role of beta-blockers in the number of acute exacerbations in patients with chronic obstructive pulmonary disease (COPD).
Hemin Khalid Saber
doaj   +1 more source

Beta-blockers in Cardiovascular Therapy: A Review

Journal of Mind and Medical Sciences, 2019
The role of beta-adrenergic receptor antagonists in cardiovascular therapy has been the subject of various studies over time, these agents representing one of the oldest class of drugs used for the treatment of cardiovascular diseases.
Camelia C. Diaconu, Dragos R. Marcu, Ovidiu G. Bratu, Ana Maria A. Stanescu, Gina Gheorghe, Andreea A. Hlescu, Dan LD. Mischianu, Maria Manea   +7 more
doaj   +1 more source

An Update on the Use of Molecularly Imprinted Polymers in Beta-Blocker Drug Analysis as a Selective Separation Method in Biological and Environmental Analysis

Molecules, 2022
Beta-blockers are antihypertensive drugs and can be abused by athletes in some sport competitions; it is therefore necessary to monitor beta-blocker levels in biological samples.
Aliya Nur Hasanah, Ike Susanti, Mutakin Mutakin   +2 more
doaj   +1 more source